Camphor, Artemisinin and Sumac Phytochemicals as inhibitors against COVID-19: Computational approach.
Comput Biol Med
; 136: 104758, 2021 09.
Article
in English
| MEDLINE | ID: covidwho-1406242
ABSTRACT
Covid-19 is an emerging infectious disease caused by coronavirus SARS-CoV-2. Due to the rapid rise in deaths resulted from this infection all around the world, the identification of drugs against this new coronavirus is an important requirement. Among the drugs that can fight this type of infection; natural products are substances that serve as sources of beneficial chemical molecules for the development of effective therapies. In this study, Camphor, Artemisinin and 14 Sumac phytochemicals were docked in the active site of SARS-CoV-2 main protease (PDB code 6LU7). We have also performed molecular dynamic simulation at 100 ns with MM-GBSA/PBSA analysis for the structures with the best affinity in the binding site of the studied enzyme (Hinokiflavone and Myricetin) after docking calculations to consider parameters like RMSD, covariance, PCA, radius of gyration, potential energy, temperature and pressure. The result indicates that Hinokiflavone and Myricetin are the structures with best affinity and stability in the binding site of the studied enzyme and they respect the conditions mentioned in Lipinski's rule and have acceptable ADMET proprieties; so, these compounds have important pharmacokinetic properties and bioavailability, and they could have more potent antiviral treatment of COVID-19 than the other studied compounds.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Rhus
/
Artemisinins
/
COVID-19
Limits:
Humans
Language:
English
Journal:
Comput Biol Med
Year:
2021
Document Type:
Article
Affiliation country:
J.compbiomed.2021.104758
Similar
MEDLINE
...
LILACS
LIS